A new trading day began on Monday, with Atyr Pharma Inc (NASDAQ: ATYR) stock price down -3.21% from the previous day of trading, before settling in for the closing price of $0.75. ATYR’s price has ranged from $0.64 to $7.29 over the past 52 weeks.
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 34.28%. Meanwhile, its annual earnings per share averaged 2.49%. With a float of $95.56 million, this company’s outstanding shares have now reached $97.99 million.
Atyr Pharma Inc (ATYR) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Atyr Pharma Inc is 2.48%, while institutional ownership is 63.39%. The most recent insider transaction that took place on Oct 08 ’25, was worth 612,437. In this transaction Director of this company bought 682,001 shares at a rate of $0.90, taking the stock ownership to the 1,095,024 shares. Before that another transaction happened on Oct 09 ’25, when Company’s Director bought 317,999 for $0.94, making the entire transaction worth $299,364. This insider now owns 1,413,023 shares in total.
Atyr Pharma Inc (ATYR) Latest Financial update
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -0.18 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.15 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 2.49% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 14.14% during the next five years compared to 34.28% growth over the previous five years of trading.
Atyr Pharma Inc (NASDAQ: ATYR) Trading Performance Indicators
Here are Atyr Pharma Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 5.93. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 374.37.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.83, a number that is poised to hit -0.19 in the next quarter and is forecasted to reach -0.63 in one year’s time.
Technical Analysis of Atyr Pharma Inc (ATYR)
The latest stats from [Atyr Pharma Inc, ATYR] show that its last 5-days average volume of 2.56 million was inferior to 4.69 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 23.41%.
During the past 100 days, Atyr Pharma Inc’s (ATYR) raw stochastic average was set at 1.47%, which indicates a significant decrease from 20.89% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0523 in the past 14 days, which was lower than the 0.1724 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.8239, while its 200-day Moving Average is $3.1932. Now, the first resistance to watch is $0.7472. This is followed by the second major resistance level at $0.7685. The third major resistance level sits at $0.7895. If the price goes on to break the first support level at $0.7049, it is likely to go to the next support level at $0.6839. The third support level lies at $0.6626 if the price breaches the second support level.
Atyr Pharma Inc (NASDAQ: ATYR) Key Stats
With a market capitalization of 71.13 million, the company has a total of 97,987K Shares Outstanding. Currently, annual sales are 240 K while annual income is -64,020 K. The company’s previous quarter sales were 190 K while its latest quarter income was -25,740 K.
